LJP 1586 是一种胺基氨基脲敏感胺氧化酶 (SSAO) 活性抑制剂。 LJP 1586 是一种具有口服有效且选择性的啮齿动物和人类 SSAO 活性抑制剂，IC50 值在 4 至 43 nM 之间。LJP 1586 对中性粒细胞积累具有显着的剂量依赖性抑制作用。

This is a hypoxia-inducible factor-1 (HIF-1 a) 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1 subunit is stabilized in response to a lack of oxygen. This part of HIF-1 binds to the von Hippel-Lindau factor (VHL) an E3 ubiquitin ligase, and the proline 564 is absolutely critical to the binding process.

Dihydroevocarpine shows potent anti-Helicobacter pylori activity with the minimum inhibitory concentration (MIC) value of 10-20 microg/ml. Dihydroevocarpine is a moderate modulator of p-glycoprotein (p-gp) activity; it shows more potent inhibitory effects against MAO-B compared to MAO-A.